Regulators split on gene therapy as patient shows signs of cancer.
Check
Erika
E
D048868:Adaptor Proteins, Signal Transducing; D002675:Child, Preschool; D002986:Clinical Trials as Topic / Q000009:adverse effects*; D004268:DNA-Binding Proteins / Q000235:genetics; D005602:France; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D060588:LIM Domain Proteins; D007938:Leukemia / Q000209:etiology* / Q000235:genetics; D008297:Male; D008667:Metalloproteins / Q000235:genetics; D011518:Proto-Oncogene Proteins; D012190:Retroviridae / Q000235:genetics; D016511:Severe Combined Immunodeficiency / Q000628:therapy*
D048868:Adaptor Proteins, Signal Transducing; D004268:DNA-Binding Proteins; D060588:LIM Domain Proteins; C085117:LMO2 protein, human; D008667:Metalloproteins; D011518:Proto-Oncogene Proteins